tradingkey.logo
tradingkey.logo
Buscar

CeriBell Inc

CBLL
Añadir a la lista de seguimiento
19.550USD
-0.450-2.25%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
741.78MCap. mercado
PérdidaP/E TTM

Más Datos de CeriBell Inc Compañía

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

Información de CeriBell Inc

Símbolo de cotizaciónCBLL
Nombre de la empresaCeribell Inc
Fecha de salida a bolsaOct 11, 2024
Director ejecutivoChao (Xingjuan)
Número de empleados281
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 11
Dirección360 N. Pastoria Avenue
CiudadSUNNYVALE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94085
Teléfono18004360826
Sitio Webhttps://ceribell.com/
Símbolo de cotizaciónCBLL
Fecha de salida a bolsaOct 11, 2024
Director ejecutivoChao (Xingjuan)

Ejecutivos de CeriBell Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.01M
+0.39%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.03M
-1.36%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
143.70K
-1.37%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
95.85K
-1.45%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
25.23K
+31.07%
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Juliet Tammenoms Bakker
Ms. Juliet Tammenoms Bakker
Independent Director
Independent Director
--
--
Dr. Lucian Iancovici, M.D.
Dr. Lucian Iancovici, M.D.
Independent Director
Independent Director
--
--
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.01M
+0.39%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.03M
-1.36%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
143.70K
-1.37%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
95.85K
-1.45%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
25.23K
+31.07%
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de CeriBell Inc?

Los cinco principales accionistas de CeriBell Inc son: Dr. Josef Parvizi, M.D., Ph.D.

¿Cuántas instituciones poseen acciones de CeriBell Inc (CBLL)?

A fecha de 2026Q1, 236 instituciones poseen acciones de CeriBell Inc, con un valor de mercado combinado de aproximadamente 31.90M, lo que representa el 84.99% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -1637325.00.

¿Cuál es la mayor fuente de ganancias de CeriBell Inc?

El 2026Q1, el segmento empresarial EEG recorders and EEG headbands, point in time generó la ganancia más alta para CeriBell Inc, ascendiendo a 67.33M y representando el 75.60% de la ganancia total.